Baird took its Henry Schein Inc. [NASDAQ:HSIC] rating to the equivalent of Outperform from Neutral, and the price target to $79 from $70, in a research note dated January 4, 2021. That figure represents around a 18.16% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with Barrington Research’s analysts upgrading the shares from “a Mkt perform” rating to “an Outperform” rating in a research note to investors issued in early November. Meanwhile, Barrington Research had lowered its rating on HSIC to “Mkt perform” from the earlier “an Outperform”, in a research note produced for clients May 06, 2020. In addition, there was an upgrade from Goldman on April 07, 2020. The rater changed HSIC from “a Neutral” to “a Buy”.
Is Henry Schein Inc. [NASDAQ:HSIC] a Good Buy Right Now?
It should be noted that HSIC technical indicators for short, intermediate as well as long term progress have placed an overall average of 80% as Buy. The average signal changed from 80% Buy in the last week and compares with 72% Buy in the past month. Data from Henry Schein Inc.’s Trend Spotter indicated that the signals were Bullish. The stock current average is 0.74 million shares in the past 20 days and the short term average signal indicates a 50% Buy. In the last 50 days, the average trading volume was 0.98 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.98 million shares.
HSIC Price Performance
On Wall Street, Henry Schein Inc. [NASDAQ:HSIC] finished Thursday’s session up 1.55% at $66.86. The stock went up to $66.94 at the same session while its lowest single day price was $65.425. In the last five days, it saw a rise of about 0.63%, Henry Schein Inc. shares gained by almost 0.21% since the beginning of the year. However, the share price has dropped to as low as -9.64% below its one year high. On 02/19/20, the company shares recorded $73.99, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 03/23/20, the same year at $41.85. The company’s shares have declined by -0.39% in the past year. The 50-day SMA achieved is $65.69 while the 200-day SMA is $60.98. Volume dropped to 0.4 million from 0.49 million in the previous session.
Henry Schein Inc. [HSIC] Valuation Measures
Notably, Henry Schein Inc. [HSIC] stock can be classified as a good candidate in the listing of underestimated low-priced Medical Distribution companies to purchase soonest possible with the prevailing 12-month PE ratio of 16.44. The measure means the stock is exchanging at a discount as compared to the 17.60x trailing earnings of the industry. It can be helpful for investors to consider historical price-sales ratio, more specifically, a 0.98 PS value ratio is reported for the last one year of reported earnings. That is higher than the industry average of 0.49 which means HSIC serve an attractive investment opportunity compared to its competitors.
HSIC Stock Support And Resistance Levels
On the 24-hour scale, the immediate backing is perceived around 65.88 level, and in case of violation of this particular level, it will cause more drop to 64.89 level. On the upper level, 67.92 is still the key resistance. The stock may increase to the subsequent resistance at 67.39. The Relative Strength Index (RSI) pinned on the 14-day chart is 51.15, implying a neutral technical stance while the MACD stands at -1.16, meaning price will decrease in the next trading period. Percent R indicator moved to 72.40%, implying bearish price movement. Stochastic %K at 16.11% suggest selling the stock.
What is the short interest in Henry Schein Inc.?
Short interest in the Henry Schein Inc. stock has surged, increasing by 0.48 million shares to total 5.26 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 5.74 million, data from Yahoo Finance shows. The decrease of -9.13% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 4.80% of the overall float for the stock.
Henry Schein Inc.’s Biggest Shareholders: Who Owns Henry Schein Inc. [HSIC]?
Filings by The Vanguard Group, Inc. showed that the firm now holds a total of 15,411,479 shares or roughly 10.79% of the outstanding HSIC shares. This means their shares have reduced by -1,043,154 from the 15,411,479 the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, Generation Investment Management updated stake is worth $863,870,699. Details in the latest 13F filings reveal that Longview Partners LLP disposed off their -3.39% stake valued at $862,029,568 while BlackRock Fund Advisors added theirs at $526,917,618. During the last quarter, Longview Partners LLP liquidated -470,882 of its shares in Henry Schein Inc. while BlackRock Fund Advisors bought 334,320 shares. The SSgA Funds Management, Inc.’s holdings currently number 7,479,220 shares at $500060649.2. According to the firm’s last 13F report, Brown Brothers Harriman & Co. shares in the company at filing stood at 4,891,381 shares, roughly $314,564,712.
HSIC Earnings Forecast For The Current Quarter
Henry Schein Inc. [HSIC] is expected to report strong earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $2.87B and an earnings per share of $0.99 for Dec 2020. Looking further ahead, the company is expected to report revenue of $2.62B at an EPS of $0.86 for Mar 2021. The estimates represent upside of 11.20% and 27.93% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.
HSIC Earnings Estimates For The Current Year
For the financial year, Henry Schein Inc. [NASDAQ:HSIC] is expected to bring in revenue of $9.83B. The returns are nearly $-160.0 million lower than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 2.96, lower than that of FY19 by -$0.55. Estimates put this year’s earnings growth at -15.70%, 28.00% for the next, and at an annual 5.43% over the next 5-year period. As for sales, forecasts are for a decrease of -1.50% in the current fiscal year and a further 11.20% over the following year.